Dr. Anne Chiang recently joined On Air, the podcast from
@onclive.bsky.social , to discuss the rapidly evolving treatment landscape in small cell #lungcancer and what this new era of innovation means for patients.
🎧 onclive.com/view/integra...
#OncLiveOnAir #SCLC
Revisit Every #OncLiveOnAir Episode From September 2025 #oncology
Read the full recap! ⬇️
www.onclive.com/view/revisit...
Revisit Every OncLive On Air Episode From June 2025
#podcast #OncLiveOnAir
www.onclive.com/view/revisit...
In the latest episode of #OncLiveOnAir 🎙️, Drs Liliana Bustamante and Jessica Stine, of Florida Cancer Specialists & Research Institute, discuss their unique journeys toward choosing oncology careers and the importance of mentorship between colleagues.
🎧: www.onclive.com/view/peer-su...
In the latest episode of #OncLiveOnAir, Chandler Park, MD, of Norton Cancer Institute, discusses the main regimens in the current frontline #BladderCancer treatment paradigm. 🎙️✨ #blcsm #podcasts #OncLive
www.onclive.com/view/compreh...
Revisit Every OncLive On Air Episode From March 2025
#OncLiveOnAir #Oncology #podcast
www.onclive.com/view/revisit...
In case you missed it, read a recap of the episodes of #OncLiveOnAir that aired in February 2025!
www.onclive.com/view/revisit...
In our latest episode of #OncLiveOnAir, Dr Rachna Shroff of the University of Arizona Cancer Center discussed the SWOG S1815 trial of a triplet regimen in patients with newly diagnosed, advanced biliary tract cancer.
@rachnatshroff.bsky.social #oncology #podcast
www.onclive.com/view/triplet...
In today’s episode of #OncLiveOnAir, Christopher L. Moertel, MD, discusses the significance of the FDA approval of mirdametinib, based on efficacy and safety data from the phase 2 ReNeu trial.
LISTEN: www.onclive.com/view/da-appr...
#oncology #MedEd
⭐️ NEW PODCAST DROPPED ⭐️
In our latest episode of #OncLiveOnAir, Dr Aditya Bardia of the UCLA Health Jonsson Comprehensive Cancer Center
discussed the January 2025 #FDAapproval of Dato-DXd for HR–positive, HER2-negative breast cancer.
🎧 LISTEN 🎧:
www.onclive.com/view/fda-app...
#FDA #BCSM #podcast
🎙️ Time to tune in 🎧
In our latest episode of #OncLiveOnAir, Drs Mark B. Geyer of @mskcancercenter.bsky.social and Elias Jabbour of @mdanderson.bsky.social discussed the role of ponatinib in Ph+ ALL, efficacy data, and more.
LISTEN:
www.onclive.com/view/ponatin...
@markgeyermd.bsky.social #leusm
Thanks to staff of #OncLiveOnAir for the chance to discuss abstracts on ALL from #ASH24. @uwmedicine.bsky.social @fredhutch.bsky.social
www.onclive.com/view/blinatu...
In this episode of #OncLiveOnAir, Ryan Cassaday, MD, of Fred Hutch provides insight on several trials assessing blinatumomab in B-cell acute lymphoblastic leukemia.
#leusm #hematology
LISTEN: www.onclive.com/view/blinatu...
Revisit Every OncLive On Air 🎙️🎧 Episode From December 2024 #oncology #OncLiveOnAir www.onclive.com/view/revisit...
In this episode of #OncLiveOnAir 🎙️🎧, Onyee Chan, MD, of
@moffittnews.bsky.social, and Bradley D. Hunter, MD, of
Intermountain Healthcare, discuss evolving treatment strategies in chronic myeloid leukemia. Listen now: onclive.com/view/ascimin... #leusm #medtwitter #oncology
A new episode of #OncLiveOnAir 🎙️ has aired! Stacey A. Cohen, MD, of @fredhutch.bsky.social @uwmedicine.bsky.social, sheds light on the evolving role of circulating tumor DNA in clinical decision-making for patients with CRC. Listen now 🎧: onclive.com/view/the-evo... #crcsm #medtwitter #oncology
Listen to Andre Goy, MD of @John Theurer Cancer Center at Hackensack University Medical Center highlight top hematologic oncology research from the 2024 ASH Annual Meeting.
Tune in here: www.onclive.com/.../unpackin....
#OncLiveOnAir #hematology #oncology